Latest news with #distribution
Zawya
8 hours ago
- Health
- Zawya
Abu Dhabi launches operations at its regional vaccine distribution hub
Abu Dhabi, UAE – The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate of Abu Dhabi, has announced the operational launch of the region's vaccine distribution hub in Abu Dhabi, following the arrival of the facility's first shipments. Located in Abu Dhabi and developed in partnership with leading global and regional stakeholders, the hub is a strategic milestone in the Emirate's vision to strengthen global health security, ensure equitable vaccine access, and build resilient supply chains across the region. Located in KEZAD and operated by Rafed, a subsidiary of PureHealth, the hub was developed in collaboration with the Department of Health – Abu Dhabi, Abu Dhabi Investment Office (ADIO), GSK, AD Ports Group, Etihad Cargo, and KEZAD Group. It is a cornerstone of the UAE's expanding life sciences ecosystem and is designed to improve vaccine access across the region. The hub leverages Abu Dhabi's strategic location, its advanced cold-chain logistics infrastructure, and a regulatory environment that is both agile and supportive of innovation. This hub reflects Abu Dhabi's model of cross-sector collaboration uniting government, biopharma, logistics, and innovation under one ecosystem. The activation of the hub follows a strategic agreement signed between DoH and GSK during Abu Dhabi Global Healthcare Week in 2024 to establish regional vaccine distribution capabilities in the emirate. Now realized, the facility becomes GSK's first vaccine distribution centre in the Middle East and the fourth worldwide, further solidifying Abu Dhabi's role in supporting regional health security and global supply chain resilience. The hub's activation also marks one of the first major operational milestones under HELM – Abu Dhabi's Life Science Cluster, which was officially launched in April 2025 during Abu Dhabi Global Health Week. As the emirate's flagship platform to drive life sciences investment, innovation, and global collaboration, HELM brings together government, industry, and academia to strengthen Abu Dhabi's position as a preferred global partner in precision health, pharmaceutical manufacturing, and biopharma logistics. The hub's integration under HELM demonstrates how Abu Dhabi is translating its life sciences vision into operational outcomes that drive regional impact. H.E Dr. Noura Khamis Al Ghaithi, Undersecretary of the Department of Health – Abu Dhabi, said: 'The operational launch of Abu Dhabi's regional vaccine hub signals our readiness to serve the region with speed, precision, and reliability. More than a logistics milestone, this reflects our long-term vision to position Abu Dhabi as a trusted partner in global health where innovation and resilience translate into timely access and measurable public health impact. Through this hub, we are making vaccines more accessible to communities across borders and strengthening the UAE's leadership in preventive, future-ready healthcare.' The facility will manage a portfolio of more than 20 vaccines, including those for paediatric and adult populations, supporting lifelong immunisation strategies across multiple markets. Designed for scalability, the hub can accommodate emerging vaccine technologies and increased regional demand, while maintaining the highest global quality and safety standards. Boyd Chongphaisal, Vice President and General Manager, GSK Gulf, commented: 'The launch of our vaccine distribution hub in Abu Dhabi represents a shared commitment to health security, innovation, and access. Through our strategic partnership with DoH and local stakeholders, we are combining scientific excellence with operational strength to ensure timely, efficient delivery of vaccines across the region. The integration of this hub under HELM further demonstrates GSK's pioneering stance and alignment with Abu Dhabi's vision for driving impactful outcomes in the life sciences sector on a regional and global scale. This initiative is also a testament to Abu Dhabi's position in the global value chain, strengthening its role in global health and innovation.' Rafed, the operator of the facility, has deployed advanced cold-chain and smart distribution technologies that preserve vaccine integrity and ensure end-to-end visibility throughout the logistics process. The hub is fully integrated with Etihad Cargo's PharmaLife network, which connects Abu Dhabi to more than 100 international destinations and offers time-sensitive, temperature-controlled freight services tailored for pharmaceutical products. Mohammad Mustafa Saeed, Chief Executive Officer of Rafed added: 'As a PureHealth company, Rafed is committed to delivering healthcare excellence through world-class pharmaceutical logistics. The launch of this regional vaccine distribution hub is a tangible expression of our strategy to strengthen health systems, improve access, and build resilience across borders. By deploying advanced cold-chain and smart distribution technologies, we are enabling real-time, end-to-end visibility. We remain focused on supporting governments and health partners with confidence and reliability to achieve better health outcomes for communities from Abu Dhabi across the Middle East, Africa, and South Asia.' The facility is expected to distribute millions of doses annually, shortening delivery timelines across the region and improving the integrity of vaccine supply. Stanislas Brun, Chief Cargo Officer at Etihad Airways added: 'Etihad Cargo's participation in this initiative reflects our continued investment in healthcare logistics. Our network and specialised PharmaLife product play a critical role in transporting temperature-sensitive vaccines reliably and efficiently across the region. We are proud to support Abu Dhabi's vision of becoming a global leader in life sciences and supply chain excellence.' The facility's activation significantly strengthens Abu Dhabi's life sciences value chain and supports the UAE's ambition to serve as a global hub for innovation-led, knowledge-based industries. Its operational readiness will help improve vaccine access, reduce delivery lead times, and address public health needs through a more proactive and resilient healthcare model. Pharmaceutical manufacturers and partners interested in leveraging Abu Dhabi's vaccine logistics capabilities are invited to join HELM and explore opportunities through The hub is expected to expand in scale and scope as Abu Dhabi continues to invest in strengthening its global life sciences footprint. About the Department of Health – Abu Dhabi (DoH): The Department of Health – Abu Dhabi is the regulative body of the healthcare sector in the Emirate of Abu Dhabi. Committed to ensuring excellence in healthcare, DoH monitors the health status of the population while shaping the regulatory framework for the health system. This includes inspecting against regulations, enforcing standards and encouraging the adoption of world-class best practices and performance targets by all healthcare providers in the Emirate. Abu Dhabi remains dedicated to shaping the future of healthcare by establishing an intelligent and sustainable ecosystem that prioritises health, longevity and quality of life for all community members. Leveraging state-of-the-art infrastructure and cutting-edge capabilities, DoH continues to develop and implement initiatives and programmes in line with its strategic focus areas, Healthy Population, Best-in-Class Care and Resilience and Innovation. These efforts reflect DoH's unwavering commitment to predicting, preventing and personalising healthcare for every individual. For further information on DOH, visit and follow on X, Instagram, Facebook, LinkedIn and YouTube. For media inquiries, please contact: Mariam Al Marzooqi, msalmarzooqi@
CBC
13 hours ago
- Health
- CBC
Attacks near aid sites kill at least 85 in Gaza
WARNING: Video contains graphic images | At least 85 people were killed near aid sites in Gaza over the weekend, according to Gaza's Health Ministry. The danger at the large distribution sites have some in the region choosing smaller locations instead.
Wall Street Journal
2 days ago
- General
- Wall Street Journal
News Quiz for July 19, 2025
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit
Globe and Mail
3 days ago
- Business
- Globe and Mail
M Split Corp. Monthly Dividend Declared for Class I Preferred Shares
TORONTO, July 18, 2025 (GLOBE NEWSWIRE) -- M Split Corp. ("M Split") declares its monthly distribution of $0.03125 per share ($0.375 annually) for Class I Preferred shareholders. The Class I Preferred share dividends are paid at an annual rate of 7.50% based on the $5 notional issue price. Distributions are payable August 8, 2025 to shareholders on record as at July 31, 2025. M Split invests in common shares of Manulife Financial Corporation, the largest life insurer in Canada offering financial products and wealth management services.
Yahoo
3 days ago
- Business
- Yahoo
North American Financial 15 Split Corp. Monthly Dividend Declaration for Class A & Preferred Share
TORONTO, July 18, 2025 (GLOBE NEWSWIRE) -- North American Financial 15 Split Corp. (The "Company") declares its regular monthly distribution of $0.11335 for each Class A share ($1.3602 annualized) and $0.07292 for each Preferred share ($0.875 annually). Distributions are payable August 8, 2025 to shareholders on record as at July 31, 2025. Since inception Class A shareholders have received a total of $18.08 per share and Preferred shareholders have received a total of $12.20 per share inclusive of this distribution, for a combined total of $30.28. The Company invests in a high quality portfolio consisting of 15 financial services companies made up of Canadian and U.S. issuers as follows: Bank of Montreal, The Bank of Nova Scotia, Canadian Imperial Bank of Commerce, Royal Bank of Canada, Toronto-Dominion Bank, National Bank of Canada, Manulife Financial Corporation, Sun Life Financial, Great-West Lifeco, CI Financial Corp, Bank of America, Citigroup Inc., Goldman Sachs Group, JP Morgan Chase & Co. and Wells Fargo & Co. Distribution Details Class A Share (FFN) $0.11335 Preferred Share ( $0.07292 Record Date: July 31, 2025 Payable Date: August 8, 2025 Investor Relations: 1-877-478-2372 Local: 416-304-4443 info@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
